Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer

Journal of Molecular Diagnostics

Volumn 17, Issue 2, 2015, Pages 162-170

  Trujillano, Daniel ^a   Weiss, Maximilian E R ^a   Schneider, Juliane ^a   Köster, Julia ^a   Papachristos, Efstathios B ^a   Saviouk, Viatcheslav ^a   Zakharkina, Tetyana ^a   Nahavandi, Nahid ^a   Kovacevic, Lejla ^a   Rolfs, Arndt ^a,b  

^a CENTOGENE AG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENOMIC DNA; BRCA2 PROTEIN, HUMAN;

ADULT; AMPLICON; ARTICLE; BIOINFORMATICS; CANCER PATIENT; DATA BASE; DNA LIBRARY; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; NEXT GENERATION SEQUENCING; PATHOGENICITY; PREDICTIVE VALUE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; OVARY TUMOR; PROCEDURES;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 84922628243     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.11.004     Document Type: Article

References (39)

1. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, and W. Ding A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
2. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, and G. Micklem Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
3. A. Antoniou, P.D. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, N. Loman, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D.M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O.-P. Kallioniemi, D. Thompson, C. Evans, J. Peto, F. Lalloo, D.G. Evans, and D.F. Easton Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117 1130
4. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, I. Fan, J. Tang, S. Li, S. Zhang, P.A. Shaw, and S.A. Narod Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada J Natl Cancer Inst 98 2006 1694 1706
5. L. Bordeleau, S. Panchal, and P. Goodwin Prognosis of BRCA-associated breast cancer: a summary of evidence Breast Cancer Res Treat 119 2010 13 24
6. S. Pruthi, B.S. Gostout, and N.M. Lindor Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer Mayo Clin Proc 85 2010 1111 1120
7. E.B. Claus, J.M. Schildkraut, W.D. Thompson, and N.J. Risch The genetic attributable risk of breast and ovarian cancer Cancer 77 1996 2318 2324
8. M.C. King, J.H. Marks, J.B. Mandell New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
9. A.H. van der Hout, A.M. van den Ouweland, R.B. van der Luijt, H.J. Gille, D. Bodmer, H. Brüggenwirth, I.M. Mulder, P. van der Vlies, P. Elfferich, M.T. Huisman, A.M. ten Berge, J. Kromosoeto, R.P. Jansen, P.H. van Zon, T. Vriesman, N. Arts, M.B. Lange, J.C. Oosterwijk, H. Meijers-Heijboer, M.G. Ausems, N. Hoogerbrugge, S. Verhoef, D.J. Halley, Y.J. Vos, F. Hogervorst, M. Ligtenberg, and R.M. Hofstra A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting Hum Mutat 27 2006 654 666
10. W. Liu, D.I. Smith, K.J. Rechtzigel, S.N. Thibodeau, and C.D. James Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations Nucleic Acids Res 26 1998 1396 1400
11. K. De Leeneer, I. Coene, B. Poppe, A. De Paepe, and K. Claes Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden J Mol Diagn 11 2009 415 419
12. A. Gerhardus, H. Schleberger, B. Schlegelberger, and D. Gadzicki Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review Eur J Hum Genet 15 2007 619 627
13. K. De Leeneer, I. Coene, B. Poppe, A. De Paepe, and K. Claes Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms Clin Chem 54 2008 982 989
14. F. Coulet, F. Pires, E. Rouleau, C. Lefol, S. Martin, C. Colas, O. Cohen-Haguenauer, I. Giurgea, A. Fajac, C. Noguès, L. Demange, A. Hardouin, R. Lidereau, and F. Soubrier A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis Genet Test Mol Biomarkers 14 2010 677 690
15. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 2002 e57
16. N. Puget, D. Stoppa-Lyonnet, O.M. Sinilnikova, S. Pagès, H.T. Lynch, G.M. Lenoir, and S. Mazoyer Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions Cancer Res 59 1999 455 461
17. T.S. Frank, S.A. Manley, O.I. Olopade, S. Cummings, J.E. Garber, B. Bernhardt, K. Antman, D. Russo, M.E. Wood, L. Mullineau, C. Isaacs, B. Peshkin, S. Buys, V. Venne, P.T. Rowley, S. Loader, K. Offit, M. Robson, H. Hampel, D. Brener, E.P. Winer, S. Clark, B. Weber, L.C. Strong, and A. Thomas Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J Clin Oncol 16 1998 2417 2425
18. K.M. Frizzell, and W.L. Kraus PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2? Breast Cancer Res 11 2009 111
19. C.M. Annunziata, and S.E. Bates PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer F1000 Biol Rep 2010 2
20. S.L. Chan, and T. Mok PARP inhibition in BRCA-mutated breast and ovarian cancers Lancet 376 2010 211 213
21. J. Stebbing, P. Ellis, and A. Tutt PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers Future Oncol 6 2010 485 486
22. J.A. De Soto, and C.X. Deng PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci 3 2006 117 123
23. R.S. Tuma PARP inhibitors: will the new class of drugs match the hype? J Natl Cancer Inst 101 2009 1230 1232
24. K. Wang, M. Li, and H. Hakonarson ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Res 38 2010 e164
25. J.T. Robinson, H. Thorvaldsdóttir, W. Winckler, M. Guttman, E.S. Lander, G. Getz, and J.P. Mesirov Integrative genomics viewer Nat Biotechnol 29 2011 24 26
26. T. Walsh, M.K. Lee, S. Casadei, A.M. Thornton, S.M. Stray, C. Pennil, A.S. Nord, J.B. Mandell, E.M. Swisher, and M.C. King Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci U S A 107 2010 12629 12633
27. M. Chan, S.M. Ji, Z.X. Yeo, L. Gan, E. Yap, Y.S. Yap, R. Ng, P.H. Tan, G.H. Ho, and P. Ang Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform J Mol Diagn 14 2012 602 612
28. C.J. Mattocks, M.A. Morris, G. Matthijs, E. Swinnen, A. Corveleyn, E. Dequeker, C.R. Müller, V. Pratt, A. Wallace, and E.V. Group A standardized framework for the validation and verification of clinical molecular genetic tests Eur J Hum Genet 18 2010 1276 1288
29. R.G. Newcombe Two-sided confidence intervals for the single proportion: comparison of seven methods Stat Med 17 1998 857 872
30. S.V. Tavtigian, A.M. Deffenbaugh, L. Yin, T. Judkins, T. Scholl, P.B. Samollow, D. de Silva, A. Zharkikh, and A. Thomas Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral J Med Genet 43 2006 295 305
31. K. De Leeneer, J. Hellemans, J. De Schrijver, M. Baetens, B. Poppe, W. Van Criekinge, A. De Paepe, P. Coucke, and K. Claes Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations Hum Mutat 32 2011 335 344
32. G. Michils, S. Hollants, L. Dehaspe, J. Van Houdt, Y. Bidet, N. Uhrhammer, Y.J. Bignon, J.R. Vermeesch, H. Cuppens, and G. Matthijs Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing J Mol Diagn 14 2012 623 630
33. I. Hernan, E. Borràs, M. de Sousa Dias, M.J. Gamundi, B. Mañé, G. Llort, J.A. Agúndez, M. Blanca, and M. Carballo Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing J Mol Diagn 14 2012 286 293
34. J.F. Thompson, J.G. Reifenberger, E. Giladi, K. Kerouac, J. Gill, E. Hansen, A. Kahvejian, P. Kapranov, T. Knope, D. Lipson, K.E. Steinmann, and P.M. Milos Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations Genome Res 22 2012 340 345
35. J.E. Morgan, I.M. Carr, E. Sheridan, C.E. Chu, B. Hayward, N. Camm, H.A. Lindsay, C.J. Mattocks, A.F. Markham, D.T. Bonthron, and G.R. Taylor Genetic diagnosis of familial breast cancer using clonal sequencing Hum Mutat 31 2010 484 491
36. H. Ozcelik, X. Shi, M.C. Chang, E. Tram, M. Vlasschaert, N. Di Nicola, A. Kiselova, D. Yee, A. Goldman, M. Dowar, B. Sukhu, R. Kandel, and K. Siminovitch Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer J Mol Diagn 14 2012 467 475
37. J. del Valle, L. Feliubadaló, M. Nadal, A. Teulé, R. Miró, R. Cuesta, E. Tornero, M. Menéndez, E. Darder, J. Brunet, G. Capellà, I. Blanco, and C. Lázaro Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes Breast Cancer Res Treat 122 2010 733 743
38. L. Feliubadaló, A. Lopez-Doriga, E. Castellsagué, J. del Valle, M. Menéndez, E. Tornero, E. Montes, R. Cuesta, C. Gómez, O. Campos, M. Pineda, S. González, V. Moreno, J. Brunet, I. Blanco, E. Serra, G. Capellá, and C. Lázaro Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes Eur J Hum Genet 21 2013 864 870
39. B. Sikkema-Raddatz, L.F. Johansson, E.N. de Boer, R. Almomani, L.G. Boven, M.P. van den Berg, K.Y. van Spaendonck-Zwarts, J.P. van Tintelen, R.H. Sijmons, J.D. Jongbloed, and R.J. Sinke Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics Hum Mutat 34 2013 1035 1042